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Abstract
Hosts have developed diverse mechanisms to counter the pathogens they face in their natural environment. Throughout
the plant and animal kingdoms, the up-regulation of antimicrobial peptides is a common response to infection. In C.
elegans, infection with the natural pathogen Drechmeria coniospora leads to rapid induction of antimicrobial peptide gene
expression in the epidermis. Through a large genetic screen we have isolated many new mutants that are incapable of
upregulating the antimicrobial peptide nlp-29 in response to infection (i.e. with a Nipi or ‘no induction of peptide after
infection’ phenotype). More than half of the newly isolated Nipi mutants do not correspond to genes previously associated
with the regulation of antimicrobial peptides. One of these, nipi-4, encodes a member of a nematode-specific kinase family.
NIPI-4 is predicted to be catalytically inactive, thus to be a pseudokinase. It acts in the epidermis downstream of the PKCh
TPA-1, as a positive regulator of nlp antimicrobial peptide gene expression after infection. It also controls the constitutive
expression of antimicrobial peptide genes of the cnc family that are targets of TGFß regulation. Our results open the way for
a more detailed understanding of how host defense pathways can be molded by environmental pathogens.
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Introduction
Pathogenic microorganisms represent one of the most ubiqui-
tous and powerful sources of selection for higher eukaryotes
including humans [1]. Different pathogens have specific natural
host tropisms, sometimes broad, as in the case of Pseudomonas
aeruginosa [2,3], and in other cases, such as HIV, very narrow. Part
of this tropism reflects the divergent mechanisms of host resistance,
as exemplified by cultivar-specific resistance in plants [4]. The
evolution of adaptive immunity is often cited as an extreme
example of immune system evolution. But even among inverte-
brates that rely on their innate immune systems, there is evidence
for considerable variation from the phylum to the species level. For
example, in contrast to most other animal species, nematodes,
including Caenorhabditis elegans, have lost NF-kB, a key transcription
factor in immunity [5,6,7]. Studying the interaction of C. elegans
with its natural pathogens therefore sheds light on NF-kB-
independent defense pathways.
A number of natural pathogens of C. elegans have been
identified, including viruses [8], microsporidia [9], and bacteria
such as Microbacterium nematophilum [10] and Serratia marcescens
[11,12]. Drechmeria coniospora is a nematophagous fungus that infects
C. elegans and other species of nematodes [13]. When C. elegans is
sampled from its natural environment, it is often found to be
infected with D. coniospora (M-A. Felix, personal communication).
D. coniospora produces adhesive conidia that attach to the worm’s
cuticle. These germinate to produce invasive hyphae that
penetrate the cuticle and grow throughout the epidermis [14].
In C. elegans, infection with D. coniospora provokes an innate
immune response in the epidermis involving the expression of a
large number of genes including those encoding antimicrobial
peptides (AMPs) of the NLP and CNC families [15,16,17].
Certain members of each family are found in 2 distinct genomic
groups, comprising nlp-27, 28, 29, 30, 31 and 34, referred to as the
nlp-29 cluster, and cnc-1, 2, 3, 4, 5 and 11, the cnc-2 cluster. The
induction of expression of the genes of the nlp-29 cluster is strongly
dependent on the p38 MAPK pmk-1, while that of the cnc-2 cluster
genes requires the TGFß dbl-1. The expression of all the genes of
the nlp-29 cluster, and some of those of the cnc-2 cluster is also
strongly increased in the epidermis if worms are physically injured.
In this case, the up-regulation of both the nlp genes and cnc-1, cnc-5
and cnc-11 (but not cnc-2 or cnc-4) is largely dependent upon pmk-1
[16,18,19].
We have shown that for nlp-29 cluster genes, following both
infection and injury, inductive signaling passes via TPA-1, a
protein kinase C delta (PKCh) that acts upstream of TIR-1, the
nematode ortholog of SARM, and a MAPK cassette comprising
the MAP3K NSY-1, the MAP2K SEK-1, and PMK-1 [20]. This
cascade acts upstream of the STAT-like transcription factor STA-
2 that physically interacts with the C-terminus of the SLC6
transporter SNF-12 [21]. SNF-12 is found in endosome-like
vesicles in the epidermis, where it may act as a signaling platform
during the innate immune response. The elements that contribute
to signaling upstream of TPA-1/PKCh have only been partially
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ing, involving the Ga protein GPA-12 and the Gß RACK-1, while
infection specifically involves the Tribbles-like kinase NIPI-3
[18,20].
In addition to provoking the increased expression of AMPs,
wounding also triggers a rise in intracellular Ca
2+. This is
controlled by an epidermal signal transduction pathway that
includes the Ga(q) EGL-30. This pathway is required for actin-
dependent wound closure, but not for injury-induced AMP
expression [22]. On the other hand, the Death-associated protein
kinase DAPK-1 negatively regulates wound repair and AMP gene
expression [23]. Many, but not all, of the elements that act in the
epidermis also mediate the innate defenses against intestinal
pathogens and toxins [24,25,26,27,28,29,30,31,32]. Conversely,
certain genes that participate in p38 MAPK signaling in the
intestine, including dfk-2 [28] are not required for the induction of
nlp-29 [20].
Our current understanding of both epidermal and intestinal
innate immunity is far from complete. In the current study, we
therefore undertook a large genetic screen for components of the
signaling pathways that control AMP gene expression in the
epidermis. We isolated and mapped 26 mutant alleles, uncovering
6 new genes required for AMP gene induction after D. coniospora
infection. We cloned one of these genes, nipi-4 (nipi for ‘‘no
induction of peptide after Drechmeria infection’’). We show here that
nipi-4 encodes a nematode-specific protein with a kinase-like
domain that is predicted to be a pseudokinase. It acts downstream
of PKCh/TPA-1, which was previously shown to modulate the
activity of a conserved p38 MAPK cassette [20]. This provides an
illustration of an animal family-specific modulation of an innate
immune signaling pathway.
Results
A genetic screen for Nipi mutants
We undertook a large-scale genetic screen for mutants that
prevented the normal induction of a Pnlp-29::GFP reporter
transgene after infection with D. coniospora. From 130,000
mutagenized haploid genomes, we isolated 57 candidate mutant
strains. These were then subjected to a confirmatory round of
screening and outcrossing. We retained 44 mutant strains that had
a sufficiently penetrant phenotype. All behaved as if they were
carrying simple recessive alleles. To characterize these in further
detail, we first quantified reporter gene expression in uninfected
and infected worms. All mutants showed a reduction of Pnlp-
29::GFP induction with the most penetrant alleles showing
essentially a complete block of the reporter (Figure 1A).
Three strains exhibited resistance to the phorbol ester PMA. As
the only gene known to provoke PMA-resistance in C. elegans is tpa-
1 [33,34], we sequenced this gene in one mutant and thus
identified a G384E mutation. We presume that the other two
mutants are also tpa-1 alleles, but did not characterize them as
there are already more than 50 available tpa-1 alleles. For the
other 41 strains, we performed classical SNP mapping to assign
alleles to individual chromosomes, which was unambiguous for 26
of them. We then performed targeted complementation tests,
between alleles, and with candidate genes on the appropriate
chromosome. When a new allele failed to complement a candidate
gene, the corresponding gene from the mutant was sequenced.
This allowed the identification of new alleles for 4 previously
characterized Nipi genes, 6 for snf-12, 3 for nsy-1, 2 for sek-1 and 1
for sta-2. These numbers give an indication of the degree of
saturation of the screen. The remaining alleles appear to
correspond to previously uncharacterized genes. They fall into 6
complementation groups, some represented by multiple alleles
(Figure 1B, Table 1).
Molecular identification of nipi-4
One complementation group was given the name nipi-4 and
characterized in detail. Whole-genome resequencing of pooled
recombinants [35] between nipi-4(fr106) and the polymorphic
Hawaiian strain CB4856 clearly delineated a candidate region for
the mutation on the center of chromosome V (Figure 2A). Within
this region, only one nonsense mutation was found, in the gene
F40A3.5, which is predicted to encode a 396 amino acid
membrane-bound protein with a tyrosine kinase domain [36]
(Figure S1). Sequencing this gene from the other nipi-4 alleles
revealed 3 independent mutations, a different nonsense mutation
in fr71, an alteration of a splice acceptor site in fr99 that would be
predicted to lead to a severely truncated protein, and a missense
mutation in the kinase domain in fr68 (Figure 2B, Table 1). This
very strongly suggests that nipi-4 corresponds to F40A3.5. In
contrast to fr68, which has a milder phenotype, the alleles fr71, fr99
and fr106 all provoke similarly penetrant phenotype and are
predicted to correspond to null alleles (Figure 2C). Transformation
rescue confirmed the identity of nipi-4 as F40A3.5 (Figure 2D).
Interestingly, we have only identified NIPI-4/F40A3.5 ortho-
logs in nematodes. The Caenorhabditis proteins, from elegans, briggsae,
brenneri, japonica and remanei species, are predicted to be kinase-
dead, since they lack the essential aspartic acid active site residue.
In contrast, predicted NIPI-4 orthologs from non-Caenorhabditis
species like Ascaris suum and Pristionchus pacificus are expected to be
functional kinases. Conversely, only the Caenorhabditis proteins
have a tyrosine in the predicted activation loop that could
potentially be the target of phosphorylation (Figure S1). We discuss
the significance of these observations below.
nipi-4 acts cell autonomously in epidermal cells
To identify the cells in which nipi-4 is expressed, we generated
transgenic animals carrying a GFP transcriptional reporter
construct (Figure 2B). We observed expression in the epidermis
of C. elegans throughout development (Figure 3A–E). This pattern
overlaps with that of the previously characterized components of
the PKCh/p38 MAPK pathway, including snf-12 and sta-2 [21]
and suggests that nipi-4 may act in a cell-autonomous manner. To
evaluate this directly, we generated transgenic animals in which
the expression of nipi-4 was under the control of the col-19
promoter, which is expressed specifically in epidermal cells as
animals enter adulthood [37]. In these worms we observed an
essentially normal expression of Pnlp-29::GFP upon infection
(Figure 3F–G). On the other hand, expression of nipi-4 in the
intestine under the control of the vha-6 promoter [38] did not give
any rescue (Figure S2). Together, this indicates that nipi-4 acts cell-
autonomously in the epidermis to regulate antimicrobial peptide
gene expression.
nipi-4 regulates AMP gene expression after infection and
wounding
To define further the function of nipi-4, we assayed the
expression of the Pnlp-29::GFP reporter transgene in the nipi-4
mutant background under other conditions that normally lead to
its expression, including injury, exposure to PMA and osmotic
stress [16,18,20]. In a nipi-4(fr71) mutant, in addition to a near-
complete block of Pnlp-29::GFP expression after infection, there
was no induction of the reporter gene upon needle wounding or
exposure to PMA. There was, however, a strong induction of Pnlp-
29::GFP expression upon exposure to high salt, comparable to that
A Pseudokinase in C. elegans Immunity
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4(fr99) and nipi-4(fr106) (Figure 4A, and results not shown). This
suggests that nipi-4 acts downstream of the PKCh TPA-1 to
regulate nlp-29 expression specifically after wounding and
infection.
We also analyzed the expression of other genes that have been
shown to be induced upon D. coniospora infection [16]. We could
confirm by qRT-PCR that in the nipi-4(fr106) mutant, just as in
sta-2 or snf-12 mutants [21], the induction of nlp-29 after infection
was essentially abrogated. Two other genes of the nlp-29 cluster,
nlp-31 and nlp-34 were similarly affected (Figure 4B). It is
interesting to note that in the nipi-4 and sta-2 mutants the
constitutive expression of nlp-34 was reduced by 10 fold whereas it
was not greatly changed for nlp-29 and nlp-31. The genes of the
cnc-2 cluster are regulated in a manner distinct from nlp-29 as their
induction after D. coniospora infection is p38 MAPK independent.
Rather their induction requires signaling via a non-canonical
TGFb/DBL-1 pathway [19]. We found by qRT-PCR that loss of
function of nipi-4 strongly affected the constitutive expression of
cnc-1 and cnc-2 and to a lesser extent cnc-4. This parallels the
phenotype due to loss of sta-2 function (Figure 4B), as well as snf-12
[21]. Indeed, as discussed below, the constitutive expression of
Figure 1. New Nipi alleles isolated in a large scale screen. (A) Biosort quantification of the fluorescence in wild type and different mutants
strains carrying an integrated Pnlp-29::GFP reporter (frIs7) following infection including sta-2(ok1860), nipi-3(fr4), tpa-1(k530) and 38 new alleles, 11 of
which have been determined to define 6 new independent complementation groups. The average fold induction for each strain is represented after
standardization across different independent experiments by normalizing to 10 the fold induction between the wild type strain infected versus non
infected. (B) Genetic map of Nipi loci identified from screens or from candidate gene approaches. The map has been scaled to the genome sequence,
as in [48]. The Nipi genes identified in the present mutagenesis and in previous studies [15,18,20,21] (Couillault et al. submitted) are represented in
red and black respectively.
doi:10.1371/journal.pone.0033887.g001
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difficult to evaluate the extent of gene induction after infection.
Thus, like snf-12 and sta-2, nipi-4 plays a role in innate immune
signaling and influences targets of both the PKCh/p38 MAPK/
PMK-1 and TGFb/DBL-1 pathways.
Modulation of AMP gene expression by gpa-12 requires
nipi-4
Our previous dissection of the innate immune signaling
pathways that govern AMP expression in the epidermis relied
on the use of PMA to activate TPA-1/PKCh and an active form of
the Ga protein GPA-12 (GPA-12* [34]), produced under the
control of a heat-shock promoter [20,21]. As both PMA and heat-
shock have pleiotropic effects on the physiology of C. elegans,w e
developed a more refined tool, with GPA-12* under the control of
the col-19 promoter, driving its expression in the adult epidermis
[37]. We injected this construct into worms carrying an integrated
Pnlp-29::GFP reporter. In uninfected transgenic worms carrying
the Pcol-19::GPA-12* construct, we observed a very marked
increase in the expression of Pnlp-29::GFP in the epidermis from
the late L4 stage onwards. The level of reporter gene expression
was even further increased upon infection with D. coniospora
(Figure 5A & B). As expected, increased Pnlp-29::GFP expression
was totally abrogated in a tpa-1 mutant (results not shown). We
found by qRT-PCR that the transgenic strain exhibited an
Table 1. New Nipi alleles.
Allele Genomic position
1Gene Mutation Protein modification
fr103 II:5,023,842 nsy-1 C to T nonsense
fr98 II:5,026,498 nsy-1 C to T nonsense
fr86 II:5,026,945 nsy-1 G to A E836K
fr76 IV tpa-1 Unknown Unknown
fr115 IV tpa-1 Unknown Unknown
fr104 IV:105,994 tpa-1 G to A G384E (B0545.1a)
fr71 V:7,869,395 nipi-4 C to T nonsense
fr68 V:7,869,401 nipi-4 G to A G313E
fr99 V:7,869,753 nipi-4 G to A Splice acceptor
fr106 V:7,870,474 nipi-4 C to T nonsense
fr67 V:9,741,675 sta-2 G to A nonsense
fr101 X:7,818,617 sek-1 G to A D212N
fr95 X:7,818,822 sek-1 G to A G194R
fr75 X:9,030,736 snf-12 G to A nonsense
fr72 X:9,031,202 snf-12 G to A G391R
fr74 X:9,031,495 snf-12 G to A E472K
fr81 X:9,032,001 snf-12 T to G nonsense
fr102 X:9,032,231 snf-12 TA insertion Frame shift
fr70 X:9,032,686 snf-12 G to A R792K
fr73 II nipi-5
fr77 II nipi-6
fr97 III nipi-7
fr108 III nipi-7
fr110 III nipi-7
fr69 X nipi-8
fr92 X nipi-9
1WormBase Release WS228.
doi:10.1371/journal.pone.0033887.t001
Figure 2. nipi-4 encodes a pseudokinase required for the
induction of nlp-29. (A) SNP mapping with WGS. The positions of SNP
loci on Chromosome V for the fr106 allele are depicted as a XY scatter
plot, where the ratio ‘Hawaiian/total number of reads’ for each SNP is
represented, as in [35]. The region without Hawaiian SNPs contains the
mutation (red arrow). (B) Exon-intron structure of nipi-4, adapted from
WormBase (WS220), with the positions of the fr68, fr71, fr99 and fr106
mutations indicated. Also shown is the structure of the pnipi-4::GFP &
pnipi-4::NIPI-4 constructs. (C) Biosort quantification of the normalized
fluorescence ratio in wild type, sta-2(ok1860) and the 4 nipi-4 alleles fr68,
fr71, fr99 and fr106 carrying frIs7 following infection. For this and
subsequent figures, see Materials and Methods for details of the data
processing and the number of worms analyzed. The results are
representative of 3 independent experiments. (D) Biosort quantification
of the normalized fluorescence ratio in wild type, nipi-4(fr106) and nipi-
4(fr106) with a rescuing transgene pnipi-4::NIPI-4, carrying frIs7
following infection.
doi:10.1371/journal.pone.0033887.g002
A Pseudokinase in C. elegans Immunity
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33887elevated constitutive expression of nlp-29, nlp-31 and nlp-34, and
cnc-1, cnc-4, and to a lesser extent cnc-2 (Figure 5C). The results
mirrored to a striking degree the pattern of gene expression
changes induced by infection (Figure 4B). When we crossed the
Pcol-19::GPA-12* transgene into nipi-4(fr106) mutant, the elevated
expression of the Pnlp-29::GFP reporter provoked by the active
form of GPA-12 was abrogated, to a similar degree as in the sta-2
mutant background (Figure 5A). The effect of GPA-12* on the
expression of other cnc and nlp genes was also abolished in the nipi-
4(fr106) mutant, as judged by qRT-PCR (Figure 5C). Together,
these results confirm the role of nipi-4 as a novel regulator of AMP
gene expression during the infection of the worm, acting
genetically downstream of PKCh TPA-1.
Discussion
To characterize the molecular pathways that underpin anti-
fungal innate immunity in C. elegans, we previously undertook a
small-scale genetic screen for genes required for the induction of
an AMP reporter gene after infection. We isolated and
characterized 5 alleles that fall into 4 complementation groups.
This provided a framework to understand the regulation of
antimicrobial peptide expression in the C. elegans epidermis [39]. In
the current study, we chose to extend the approach, with the aim
of performing a saturating screen. Counting just the alleles that
were amenable to classical SNP mapping, we found a total of 11
complementation groups, of which 2 corresponded to genes that
had been hit in the previous screen, and 3 to genes previously
known to be involved in the regulation of nlp genes, leaving a total
of 6 new complementation groups.
The current genetic screen has reinforced the importance of the
p38 MAPK pathway as a central part of anti-fungal defenses in the
epidermis as we recovered multiple alleles of the MAP3K nsy-1
and the MAP2K sek-1. A common p38 MAPK signaling cassette is
also required for resistance to intestinal bacterial infection. In a
screen for genes that both regulate the constitutive expression of
the intestinal gene T24B8.5 and that are required for resistance to
P. aeruginosa infection, 14 nsy-1,8sek-1,7pmk-1 and 3 tir-1 alleles
were isolated, together with one allele of a new actor in the
intestinal p38 pathway, the transcription factor atf-7 [29]. Our
screens might have allowed the identification of many more
distinct genes, presumably because they were less stringent. We
may well find alleles of pmk-1 and tir-1 among the alleles that have
yet to be mapped.
The genes of the cnc-2 and nlp-29 clusters share a common
evolutionary origin [16]. It is reasonable to imagine that they were
initially regulated by a common mechanism, but this is clearly no
longer the case. Certain genes, however, participate in the
regulation of both groups of genes. Indeed, the results we obtained
using nipi-4 have reinforced observations that we previously made
with snf-12 and sta-2 mutants [21]. These 3 genes are necessary for
the induction of the genes of the nlp-29 cluster, but do not greatly
affect their constitutive level of expression. On the other hand, loss
of function of any one of the 3 essentially abolishes the constitutive
expression of cnc-1 and cnc-2. The drop in the constitutive level of
its expression is such that it is not technically possible for us to
determine reliably by qRT-PCR whether D. coniospora infection
still provokes an induction of these genes in the nipi-4, snf-12 or sta-
2 mutants. In wild-type worms, the induction of the cnc genes is
almost entirely dependent upon dbl-1. Changes in dbl-1 expression
do not however affect their constitutive expression. Nor does dbl-1
have any effect on the induction of the genes of the nlp-29 cluster
[19]. This suggests a model in which nipi-4, snf-12 and sta-2 are
involved in two different processes, one that governs the
constitutive expression of cnc-1 and cnc-2, and the other that
controls the inducibility of genes of the nlp-29 cluster. The degree
to which these two functions are interdependent remains to be
established, as does the exact impact of nipi-4 on cnc-4, as it is less
clear-cut.
In addition to these open questions, the structure of NIPI-4 itself
raises a number of issues. As mentioned above, NIPI-4-like
proteins are only found in a subset of nematodes, and are never
duplicated. Certain defense mechanisms have been lost in parasitic
nematodes such as Meloidogyne incognita [40], but a NIPI-4 homolog
can be found in Meloidogyne species and in the animal parasite
Ascaris suum, so this protein is not restricted to free-living
nematodes. Interestingly, while orthologs in A. suum and Pristionchus
pacificus possess the characteristic catalytic aspartate residue, this
residue is absent in all Caenorhabditis species, so these proteins are
predicted to be catalytically inactive pseudokinases. This suggests
that NIPI-4 has evolved a kinase-independent function in
Caenorhabditis species. NIPI-4 might compete with one or more
active kinases for substrates or binding partners. In such a
scenario, the putative kinase(s) would need to play a negative
regulatory role. The loss of catalytic activity in NIPI-4 has,
however, been mirrored by the acquisition of a potential activation
loop phosphorylation site not seen in other species. It is therefore
tempting to speculate that NIPI-4 in Caenorhabditis species is able to
donate its activation loop to another kinase following hetero-
dimerization, as is seen for example with STRAD and LKB1 [41].
NIPI-4 and all its identified orthologs possess a predicted
transmembrane segment, N-terminal to the kinase domain that
could allow its association with the membrane of one or more
classes of intracellular vesicles. We previously showed that SNF-12
is found in endosome-like vesicles, and that endocytosis is
indispensable for the transcriptional response to infection [21].
One could conjecture that NIPI-4, SNF-12 and STA-2 form a
signaling complex on endosomes that is activated following
physical association with the MAPK PMK-1. Understanding the
function of NIPI-4 at the biochemical and cellular level, an
Figure 3. The nipi-4 gene acts cell autonomously in the
epidermis. (A–E) Expression of nipi-4 is seen throughout the epidermis
(A & B)), in larvae (C) and adults (A,B,D&E), from head (D) to tail (E), in
vulval cells (arrow in B), in rectal cells (arrow in E), but not in the seam
cells (arrowhead in A), scale bar 10 mm. (F–G) nipi-4(fr71) and nipi-
4(fr71);frEx496 (Pcol-19::NIPI-4) worms strains carrying an integrated
Pnlp-29::GFP reporter (frIs7) following infection. The expression of nipi-4
in epidermal cells in the adult rescues the nipi-4 phenotype. Green and
red fluorescence is visualized simultaneously with a GFP long pass filter.
doi:10.1371/journal.pone.0033887.g003
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specific host defense pathway can be molded by the natural
pathogens found in a particular environmental niche.
Materials and Methods
Nematode strains
All strains were maintained on nematode growth media (NGM)
and fed with E. coli strain OP50, as described [42]. In addition to
the wild-type strain N2 and CB4856 that were obtained from the
Caenorhabditis Genetics Center (CGC), the following mutants were
used for complementation tests all carrying the frIs7 transgene
containing the Pnlp-29::GFP and Pcol-12::DsRed reporters [18] :
snf-12(tm692) X, sek-1(km4) X, hsp-3(ok1083) X, nsy-1(age3) II, tir-
1(tm3036) III, tpa-1(k530) IV, egl-8(n488) V and sta-2(ok1860) V.
The 4 nipi-4 alleles were outcrossed twice with N2.
Mutants Isolation
We mutagenized IG274 wild type worms carrying the frIs7
transgene with EMS using standard procedures [43]. 130,000
genomes were screened using the same criteria described in [18].
Briefly, synchronized F2 worms were infected at the L4 stage with
D. coniospora. After 24 h at 25uC, we screened for worms that failed
to show an elevated level of GFP expression after D. coniospora
infection and transferred them onto nystatin containing NGM
plates. Mutant alleles were mapped through standard genetic and
bulk SNP mapping by analysis of 20 to 30 recombinants with the
strain CB4856 [44]. Genetic complementation tests were done
between mutants located on the same chromosome, defining 6
new independent complementation groups.
Whole Genome Sequencing
nipi-4(fr106) mutation was further mapped and identified using
a whole genome sequencing-SNP mapping protocol [35]. Briefly,
nipi-4(fr106) was crossed with Hawaiian CB4856 males and 20 F2
mutant recombinant lines were isolated. The DNA of these pooled
lines was prepared using a standard protocol with proteinase K
lysis, RNAse A treatment and phenol/chloroform extraction. The
pooled DNA was subjected to whole genome sequencing in
multiplexed run with 4 samples in one sequencing lane of a v1.5
flowcell on HiSeq 2000 instrument, generating paired 100
nucleotide reads. The results were analyzed using Maqgene [45].
Figure 4. The nipi-4 gene is required for the response to infection and wounding. (A) nipi-4 mutants do not block the induction of nlp-29
expression upon osmotic stress. Biosort quantification of the normalized fluorescence ratio in wild type, sta-2(ok1860) and nipi-4(fr71) worms carrying
frIs7 following infection by D. coniospora, wounding, PMA treatment and osmotic stress. (B) Quantitative RT-PCR analysis of gene expression levels in
non- infected and infected wild type, sta-2(ok1860) and nipi-4(fr106) worms. The columns show the average expression level (arbitrary units) and SEM
from 4 experiments. The level of nlp-34 expression in control animals is set at 1024 (see Materials and Methods).
doi:10.1371/journal.pone.0033887.g004
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Infections with D. coniospora and wounding were carried out at
25uC as described [18]. Briefly, animals were infected with D.
coniospora at the L4 stage or exposed to high salt and incubated at
25uC. After 18 h, age-matched non-infected animals were used for
wounding assays, exposure to PMA, or kept as control. Exposure
of worms to high salt (350 mM NaCl) and PMA (1 mg/ml) were
done on NGM plates as previously described [20].
Constructs and transgenic lines
Pnipi-4::GFP was obtained by Gateway cloning (Invitrogen
TM).
A 2,521 bp fragment upstream of the nipi-4 start site was amplified
(with primers JEP1974-JEP1975), cloned into the pDONRP4-P1R
vector, then transferred into the destination vector pDEST-DD04-
Neo a generous gift from D. Dupuy [46] so that it was cloned
upstream of the GFP::unc-54_39UTR cassette. The Pnipi-4::GFP
was injected at 20 ng/ml together with Pttx-3::DsRed2 at 70 ng/ml
into N2 worms. Two independent lines were generated showing
the same expression pattern IG1341 wt; frEx483 and IG1342 wt;
frEx484.
Pnipi-4::NIPI-4 (pMS18) was obtained by multisite recombina-
tional Gateway cloning (Invitrogen
TM). A nipi-4 genomic fragment
comprising the entire ORF with the ATG but without the stop
codon was amplified (JEP1964–JEP1965) and cloned into
pDONR/Zeo (Invitrogen
TM). The promoter and gene entry clones
were used together with a unc-54_39UTR entry clone in a multi-
partite LR reaction intothe pJPDest R4R3vector, to produce Pnipi-
4::NIPI-4. This construct was injected at 20 ng/ml together with
pBunc-53::GFP [47] at 70 ng/ml into nipi-4(fr106);frIs7. One line
was generated IG1343 wt; frEx485.
Pcol-19::NIPI-4 was obtained by Gateway cloning (Invitro-
gen
TM). The nipi-4 gene entry clone described above was
recombined into the destination vector pCZGY1434 that contains
the promoter of col-19 (Pcol-19), a generous gift from A. Chisholm
[22]. This construct was injected at 30 ng/ml together with pBunc-
53::GFP [47] at 70 ng/ml in IG1352 nipi-4(fr71); frIs7. Two lines
were generated IG1404 wt; frEx496 and IG1405 wt; frEx497.
Pvha-6::NIPI-4::GFP (pMS21) was obtained by multisite recom-
binational Gateway cloning (Invitrogen
TM). A 1,255 bp genomic
fragment upstream of the vha-6 start site was amplified (with
primers JEP1982–JEP1983), cloned into the pDONRP4-P1R
vector. The nipi-4 gene entry clone described above and the Pvha-6
promoter entry clone were used together with GFP entry clone in
a multi-partite LR reaction into the pJPDest R4R3 vector. This
construct was injected at 2 ng/ml together with pBunc-53::GFP
[47] at 70 ng/ml in IG1352 nipi-4(fr71); frIs7. Two lines were
generated IG1410 wt; frEx498 and IG1411 wt; frEx499.
Pcol-19::GPA-12* was obtained by Gateway cloning (Invitro-
gen
TM). The DNA encoding an activated form of GPA-12 (with
the Q205L mutation) was amplified from the construct pRP2205 a
generous gift from R. Korswagen [34] with the primers JEP1976–
JEP1977, inserted into a Gateway pDONR/Zeo (Invitrogen
TM)
then recombined into the destination vector pCZGY1434 [22].
Figure 5. nipi-4 genetically interacts with the G-protein/PKCd/
p38 MAPK cascade. (A) The G-protein/PKCd/p38 MAPK cascade
regulates the expression of nlp-29 after infection and wounding. Biosort
quantification of the normalized fluorescence ratio in wild type, sta-
2(ok1860) and nipi-4(fr106) mutant worms carrying an integrated Pnlp-
29::GFP reporter, with or without a transgene carrying an activated form
of GPA-12 under the control of an epidermis promoter (Pcol-19::GPA-
12*). (B) Images of the wild type strain carrying frIs7 with (+GPA-12*) or
without (2GPA-12*) Pcol-19::GPA-12* in control animal (2Dc) or worm
infected by D. coniospora (+Dc). Green and red fluorescence is
visualized simultaneously. (C) Quantitative RT-PCR analysis of gene
expression levels in wild type and nipi-4(fr106) worms with or without
Pcol-19::GPA-12*. The columns show the average expression level
(arbitrary units) and SEM from 3 experiments. The level of nlp-34
expression in control animals is set at 1024 (see Materials and Methods).
doi:10.1371/journal.pone.0033887.g005
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53::GFP [47] at 70 ng/ml in IG274 wt; frIs7. One line was
generated IG1363 wt; frEx486 and then subsequently integrated
using Gamma rays and outcrossed several times with N2
generating IG1389 wt; frIs7 IV; frIs30.
Analysis with the COPAS Biosort
Analysis of Pnlp-29::GFP induction in the strain carrying the
frIs7 integrated array for the different treatments were all done at
the same time on worms 24 h after the L4 stage with the COPAS
Biosort (Union Biometrica
TM) [18]. The frIs7 integrated array
consists of two reporter transgenes, Pnlp-29::GFP and Pcol-
12::DsRed2. As the latter exhibits a constitutive expression in
the epidermis that is unaffected by infection or other tested
conditions, the fluorescence ratio green/red represents the
variation in Pnlp-29::GFP expression normalized for the size of
individuals [18]. The mean values are shown normalized to the
wild type control that is set to one. The number of animals used in
each experiment is given below. As previously described [18], due
to the nature of the distribution, standard deviations are not
always an informative parameter when measuring fluorescent
reporter gene expression using the Biosort. Data are, however, in
all cases representative of at least 3 independent experiments.
Number of animals quantified with the COPAS Biosort
Figure 2C: 231, 242, 197, 158, 91, 118, 139, 90, 122, 139, 67,
93
Figure 2D: 202, 182, 153, 123, 219, 120 (Combined 3
experiments)
Figure 4A: 104, 111, 98, 103, 158, 171, 160, 54, 72, 110, 139,
97, 85, 64, 81
Figure 5A: 286, 234, 542, 296, 515, 256 (Combined 3
experiments)
qRT-PCR
L4 worms were infected for 6 h at 25uC with D. coniospora.1mg
of total mRNA from infected and non-infected worms were used
for reverse transcription (Applied Biosystems
TM). Quantitative
real-time PCR were performed using 1 ml of cDNA in 10 mlo f
SYBERgreen Applied Biosystems
TM and 0.1 mM of primers on a
7500 Fast Real-Time PCR System using act-1 (JEP538-JEP539) as
a control, with nlp-29 (JEP848–JEP952), nlp-31 (JEP950–JEP953),
nlp-34 (JEP969–JEP970), cnc-1 (JEP1087–JEP1088), cnc-2
(JEP944–JEP549) and cnc-4 (JEP1124–JEP1125), for primer
sequences see [21]. Results were normalized to act-1, and then
relative expression calculated using 2((A+10)2x), A being the
normalized cycle number for nlp-34 in the non-infected sample
and x the value of interest. Control and experimental conditions
were tested in the same run. Means and SEMs were calculated
from a minimum of 3 independent experiments.
Primer sequences
JEP1966 ggggacagctttcttgtacaaagtggtaatggagctcgatcacactcca
JEP1967 ggggacaactttgtataataaagttgtttaataatggatgacgctttgac
JEP1974 ggggacaactttgtatagaaaagttgaaaagtgagcgacggattcc
JEP1975 ggggactgcttttttgtacaaacttgtctgatttttcacagtataattag
JEP1982 ggggacaactttgtatagaaaagttgtagagcatgtacctttatag
JEP1983 ggggactgcttttttgtacaaacttggggttttggtaggttttagt
Supporting Information
Figure S1 Alignment of the predicted NIPI-4 proteins.
Accession numbers for the different proteins are the following: C.
elegans NP_505028, C. remanei XP_003115465, C. brenneri
EGT43601, C. briggsae CAP37545, C. japonica JA58647. The
Ascaris and Pristonchius proteins present in Genbank (ADY47863,
PP41334) appear to have been mis-predicted. The figure presents
more plausible predictions based on manual editing, respecting
splice consensus sequences, of the output from tblastn using the C.
elegans NIPI-4 protein against the relevant genomic sequence. All
included sequences were found as significant matches with a
smallest sum probability of at least e-25. For Meloidogyne hapla,
Oncocera volvulus, Strongyloides ratti only partial sequences are
presented, no attempt to reconstruct complete sequences was
made (*). Alignments were produced with Clustal W2 (http://
www.ebi.ac.uk/Tools/msa/clustalw2/) and Boxshade (http://
www.ch.embnet.org/software/BOX_form.html). Thanks to G.
Manning for the annotation of the different domains.
(DOC)
Figure S2 Intestinal expression of NIPI-4 does not
rescue the Nipi phenotype. (A–C) wild type (A), nipi-4(fr71)
(B) and nipi-4(fr71);Pvha-6::NIPI-4 (C) worm strains carrying frIs7
following infection. The expression of nipi-4 in the intestinal cells in
the adult does not rescue the nipi-4 phenotype. Green and red
fluorescence is visualized simultaneously. The green fluorescence
at the level of the head and vulva in C is due to the co injection
marker Punc-53::GFP [47].
(EPS)
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